AAAAAA
Results: 1-25/34
Authors:
RUOTTINEN HM
RINNE UK
Citation: Hm. Ruottinen et Uk. Rinne, COMT INHIBITION IN THE TREATMENT OF PARKINSONS-DISEASE, Journal of neurology, 245, 1998, pp. 25-34
Authors:
RINNE UK
LARSEN JP
SIDEN A
WORMPETERSEN J
Citation: Uk. Rinne et al., ENTACAPONE ENHANCES THE RESPONSE TO LEVODOPA IN PARKINSONIAN-PATIENTSWITH MOTOR FLUCTUATIONS, Neurology, 51(5), 1998, pp. 1309-1314
Authors:
OLANOW CW
MYLLYLA VV
SOTANIEMI KA
LARSEN JP
PALHAGEN S
PRZUNTEK H
HEINONEN EH
KILKKU O
LAMMINTAUSTA R
MAKIIKOLA O
RINNE UK
Citation: Cw. Olanow et al., EFFECT OF SELEGILINE ON MORTALITY IN PATIENTS WITH PARKINSONS-DISEASE- A METAANALYSIS, Neurology, 51(3), 1998, pp. 825-830
Authors:
RINNE UK
BRACCO F
CHOUZA C
DUPONT E
GERSHANIK O
MASSO JFM
MONTASTRUC JL
MARSDEN CD
Citation: Uk. Rinne et al., EARLY TREATMENT OF PARKINSONS-DISEASE WITH CABERGOLINE DELAYS THE ONSET OF MOTOR COMPLICATIONS - RESULTS OF A DOUBLE-BLIND LEVODOPA CONTROLLED TRIAL, Drugs, 55, 1998, pp. 23-30
Authors:
TROCONIZ IF
NAUKKARINEN TH
RUOTTINEN HM
RINNE UK
GORDIN A
KARLSSON MO
Citation: If. Troconiz et al., POPULATION PHARMACODYNAMIC MODELING OF LEVODOPA IN PATIENTS WITH PARKINSONS-DISEASE RECEIVING ENTACAPONE, Clinical pharmacology and therapeutics, 64(1), 1998, pp. 106-116
Authors:
RUOTTINEN HM
RINNE JO
OIKONEN VJ
BERGMAN JR
HAAPARANTA MT
SOLIN OH
RUOTSALAINEN UH
RINNE UK
Citation: Hm. Ruottinen et al., STRIATAL B-[F-18]FLUORODOPA ACCUMULATION AFTER COMBINED INHIBITION OFPERIPHERAL CATECHOL-O-METHYLTRANSFERASE AND MONOAMINE-OXIDASE TYPE-B - DIFFERING RESPONSE IN RELATION TO PRESYNAPTIC DOPAMINERGIC DYSFUNCTION, Synapse, 27(4), 1997, pp. 336-346
Authors:
RUOTTINEN HM
RINNE JO
BERGMAN JR
HAAPARANTA MT
SOLIN OH
OIKONEN VJ
RUOTSALAINEN UH
RINNE UK
Citation: Hm. Ruottinen et al., PROLONGED PET IMAGING DEMONSTRATES FURTHER INCREASE IN [F-18] FLUORODOPA (FDOPA) ACCUMULATION AFTER ENTACAPONE ADMINISTRATION, Neurology, 48(3), 1997, pp. 3106-3106
Authors:
RINNE UK
BRACCO F
CHOUZA C
DUPONT E
GERSHANIK O
MASSO JFM
MONTASTRUC JL
MARSDEN CD
DUBINI A
ORLANDO N
GRIMALDI R
BERGAMASCO B
MAMOLI A
SCARPA M
SCARANO M
CANAL N
FRANCESCHI M
ALBANESE A
BENTIVOGLIO AR
BARONE P
CICARELLI G
MALESANI R
MICHELI F
MUCHNIK S
PLIEGO L
SOMOZA M
GORI HE
DOMINGUEZ R
FAMULARI A
ALJANATI R
MIKKELSEN B
OLIVE JM
BURGUERA J
MIQUEL F
GIMENEZROLDAN S
MATEO D
ALLAIN H
VERIN M
DEGOS JD
DESTEE A
WARTER JM
BERNARDI F
CHILLOTTI C
SERRA JP
GARRIGA MC
BENECKE R
PIROTTA RMN
GROSSONI M
Citation: Uk. Rinne et al., CABERGOLINE IN THE TREATMENT OF EARLY PARKINSONS-DISEASE - RESULTS OFTHE FIRST YEAR OF TREATMENT IN A DOUBLE-BLIND COMPARISON OF CABERGOLINE AND LEVODOPA, Neurology, 48(2), 1997, pp. 363-368
Authors:
MA SY
ROYTTA M
RINNE JO
COLLAN Y
RINNE UK
Citation: Sy. Ma et al., CORRELATION BETWEEN NEUROMORPHOMETRY IN THE SUBSTANTIA-NIGRA AND CLINICAL-FEATURES IN PARKINSONS-DISEASE USING DISECTOR COUNTS, Journal of the neurological sciences, 151(1), 1997, pp. 83-87
Authors:
RUOTTINEN HM
RINNE UK
Citation: Hm. Ruottinen et Uk. Rinne, A DOUBLE-BLIND PHARMACOKINETIC AND CLINICAL DOSE-RESPONSE STUDY OF ENTACAPONE AS AN ADJUVANT TO LEVODOPA THERAPY IN ADVANCED PARKINSONS-DISEASE, Clinical neuropharmacology, 19(4), 1996, pp. 283-296
Authors:
RUOTTINEN HM
RINNE UK
Citation: Hm. Ruottinen et Uk. Rinne, EFFECT OF ONE MONTHS TREATMENT WITH PERIPHERALLY ACTING CATECHOL-O-METHYLTRANSFERASE INHIBITOR, ENTACAPONE, ON PHARMACOKINETICS AND MOTOR RESPONSE TO LEVODOPA IN ADVANCED PARKINSONIAN-PATIENTS, Clinical neuropharmacology, 19(3), 1996, pp. 222-233
Authors:
MYLLYLA VV
SOTANIEMI K
MAKIIKOLA O
RINNE UK
HEINONEN EH
Citation: Vv. Myllyla et al., ROLE OF SELEGILINE IN COMBINATION THERAPY OF PARKINSONS-DISEASE, Neurology, 47(6), 1996, pp. 200-209
Authors:
MA SY
RINNE JO
COLLAN Y
ROYTTA M
RINNE UK
Citation: Sy. Ma et al., A QUANTITATIVE MORPHOMETRICAL STUDY OF NEURON DEGENERATION IN THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE, Journal of the neurological sciences, 140(1-2), 1996, pp. 40-45
Authors:
RUOTTINEN HM
RINNE UK
Citation: Hm. Ruottinen et Uk. Rinne, ENTACAPONE PROLONGS LEVODOPA RESPONSE IN A ONE MONTH DOUBLE-BLIND-STUDY IN PARKINSONIAN-PATIENTS WITH LEVODOPA RELATED FLUCTUATIONS, Journal of Neurology, Neurosurgery and Psychiatry, 60(1), 1996, pp. 36-40
Authors:
RINNE JO
LAIHINEN A
NAGREN K
RUOTTINEN H
RUOTSALAINEN U
RINNE UK
Citation: Jo. Rinne et al., PET EXAMINATION OF THE MONOAMINE TRANSPORTER WITH [C-11] BETA-CIT AND[C-11] BETA-CFT IN EARLY PARKINSONS-DISEASE, Synapse, 21(2), 1995, pp. 97-103
Authors:
HOLSHOUSER BA
KOMU M
MOLLER HE
ZIJLMANS T
KOLEM H
HINSHAW DB
SONNINEN P
VERMATHEN P
HEERSCHAP A
MASUR H
RINNE UK
DEKOSTER A
TOSK JM
Citation: Ba. Holshouser et al., LOCALIZED PROTON NMR-SPECTROSCOPY IN THE STRIATUM OF PATIENTS WITH IDIOPATHIC PARKINSONS-DISEASE - A MULTICENTER PILOT-STUDY, Magnetic resonance in medicine, 33(5), 1995, pp. 589-594
Authors:
MA SY
ROYTTA M
RINNE JO
COLLEN Y
RINNE UK
Citation: Sy. Ma et al., SINGLE SECTION AND DISECTOR COUNTS IN EVALUATING NEURONAL LOSS FROM THE SUBSTANTIA-NIGRA IN PATIENTS WITH PARKINSONS-DISEASE, Neuropathology and applied neurobiology, 21(4), 1995, pp. 341-343
Authors:
MA SY
COLLAN Y
ROYTTA M
RINNE JO
RINNE UK
Citation: Sy. Ma et al., CELL COUNTS IN THE SUBSTANTIA-NIGRA - A COMPARISON OF SINGLE SECTION COUNTS AND DISECTOR COUNTS IN PATIENTS WITH PARKINSONS-DISEASE AND IN CONTROLS, Neuropathology and applied neurobiology, 21(1), 1995, pp. 10-17
Authors:
RUOTTINEN HM
RINNE JO
RUOTSALAINEN UH
BERGMAN JR
OIKONEN VJ
HAAPARANTA MT
SOLIN OH
LAIHINEN AO
RINNE UK
Citation: Hm. Ruottinen et al., STRIATAL [F-18] FLUORODOPA UTILIZATION AFTER COMT INHIBITION WITH ENTACAPONE STUDIED WITH PET IN ADVANCED PARKINSONS-DISEASE, Journal of neural transmission, 10(2-3), 1995, pp. 91-106
Authors:
LAIHINEN AO
RINNE JO
NAGREN KA
LEHIKOINEN PK
OIKONEN VJ
RUOTSALAINEN UH
RUOTTINEN HM
RINNE UK
Citation: Ao. Laihinen et al., PET STUDIES ON BRAIN MONOAMINE TRANSPORTERS WITH CARBON-11-BETA-CIT IN PARKINSONS-DISEASE, The Journal of nuclear medicine, 36(7), 1995, pp. 1263-1267
Authors:
RINNE JO
KUIKKA J
LAIHINEN A
NAGREN K
LEHIKOINEN P
BERGSTROM K
RUOTSALAINEN U
RUOTTINEN H
RINNE UK
Citation: Jo. Rinne et al., A COMPARISON OF [I-123] BETA-CIT SPECT AND [C-11] BETA-CIT PET IN IMAGING THE MONOAMINE TRANSPORTERS IN PARKINSONS-DISEASE, Neurology, 45(4), 1995, pp. 220-220
Authors:
RUOTTINEN HM
RINNE UK
AHTILA S
KARLSSON M
KYYRO T
GORDIN A
Citation: Hm. Ruottinen et al., ENTACAPONE INCREASES LEVODOPA RESPONSE IN A ONE-MONTH DOUBLE-BLIND-STUDY IN PARKINSONIAN-PATIENTS WITH FLUCTUATIONS, Neurology, 45(4), 1995, pp. 275-275
Authors:
LAIHINEN A
RINNE JO
RUOTTINEN H
NAGREN K
LEHIKOINEN P
OIKONEN V
RUOTSALAINEN U
RINNE UK
Citation: A. Laihinen et al., DOPAMINE D1 RECEPTORS IN NORMAL AND PARKINSONIAN BRAINS STUDIED WITH [C-11] SCH 39166 AND [C-11] NNC 756, Neurology, 45(4), 1995, pp. 410-410
Authors:
RINNE JO
LAIHINEN A
RUOTTINEN H
RUOTSALAINEN U
NAGREN K
LEHIKOINEN P
OIKONEN V
RINNE UK
Citation: Jo. Rinne et al., INCREASED DENSITY OF DOPAMINE D2 RECEPTORS IN THE PUTAMEN, BUT NOT INTHE CAUDATE-NUCLEUS IN EARLY PARKINSONS-DISEASE - A PET STUDY WITH [C-11] RACLOPRIDE, Journal of the neurological sciences, 132(2), 1995, pp. 156-161
Authors:
MOLSA PK
MARTTILA RJ
RINNE UK
Citation: Pk. Molsa et al., LONG-TERM SURVIVAL AND PREDICTORS OF MORTALITY IN ALZHEIMERS-DISEASE AND MULTIINFARCT DEMENTIA, Acta neurologica Scandinavica, 91(3), 1995, pp. 159-164